v3 Template
P

PhaseV

Biotechnology / Clinical Trials Boston ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$50.0M
Funding Rounds
1
Last Funding
2025-05-13

About PhaseV

PhaseV empowers biopharma sponsors and CROs with AI/ML-driven solutions to make fast, efficient, and accurate clinical development decisions, optimizing every phase of the clinical trial process for smarter trials, faster results, and better ROI.

Products & Services

Trial Optimizer:Runs millions of simulations within minutes, benchmarks Bayesian designs, and enables real-time, data-driven trial decisions with AI-powered optimization.
Causal-ML for HTE:Identifies optimal subgroups and biomarkers by detecting heterogeneity in complex biological signals and multi-variable clinical data.
Causal Disease Modeling:Uncovers key biological factors driving disease progression and assesses their impact on clinical outcomes with AI-driven causal graphs.
Clinical Operations:Enhances clinical operations with Causal-ML driven site selection and dashboards for real-time trial and site performance analytics.
ML Early-Derived Endpoint Identification:Predicts and validates early-derived endpoints to accelerate decision-making, with proven case studies in neurology and immunology.

Specialties

AI and Machine Learning in Clinical Trials Trial Optimization Causal-ML for Heterogeneity of Treatment Effects (HTE) Causal Disease Modeling Clinical Operations Analytics Early-Derived Endpoint Identification

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 50000000
MR: -
FA: 50 million
FAN: 50000000 		D: 2025-05-13
FD: 2025-05-13 		5 investors
Series A Latest
2025-05-13
$50.0M
5 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Raviv Pryluk

CEO, Co-Founder

LinkedIn (Pro only)
E

Elad Berkman

CTO, Co-Founder

LinkedIn (Pro only)
D

Dan Goldstaub

Scientific Co-Founder

LinkedIn (Pro only)
B

Brad Carlin

Sr. Director, Data Science and Statistics

S

Sofia Villar

Scientific Advisory Board

D

David Perry

Scientific Advisory Board

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

PhaseV Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Clinical Trials
Company Size
~260 employees (est.)
Locations
Boston
Boston, MA

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro